My watch list  

86 Current news from israel

matching the following criteria

Candidate genes were discovered utilizing microbial database and dedicated computational platform


Evogene Ltd. announced a key milestone in its insect control program with the successful completion of the first computational discovery round for microbial genes with insecticidal properties. The discovery round utilized a unique computational technology infrastructure consisting of a ...


BGU and University of Colorado Researchers Develop Novel “Smart” Drug that Targets and Reduces Site-Specific Inflammation


Ben-Gurion University of the Negev and University of Colorado researchers have used a highly novel approach to create a dynamic ‘smart’ drug that is attentive to the degree of the inflammation. The three describe a novel creative development of an anti-inflammatory engineered protein in the ...


Evogene and Marrone Bio Innovations Sign Multi-Year Collaborative Agreement

Joint Discovery Efforts to Lead to Novel Insect Control Solutions


Evogene Ltd. and Marrone Bio Innovations Inc. announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the ...


PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions


PolyPid announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. application Serial Number 13/574,040, a patent covering compositions for sustained and/or controlled release of nucleic acid agents. A Notice of Allowance is the formal USPTO ...


Increased levels of carbon dioxide could threaten zinc and iron levels in plants

Study by BGU researcher and colleagues on most significant health threat from climate change featured in Nature


Crops that provide a large share of the global population with most of their dietary zinc and iron will have significantly reduced concentrations of those nutrients at the elevated levels of atmospheric CO2 anticipated by around 2050, according to research published in Nature. Given that an ...


Merck Invests in Research Partnerships in Israel to Boost Innovation


Merck is increasingly counting on partnerships with Israeli biotech companies, as demonstrated by its cooperation with Metabomed and ChanBio, both of which joined the Merck Serono Israel Bioincubator now. Merck is already cooperating with multiple Israeli start-up companies such as Qlight ...


D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator


D-Pharm Ltd announced receipt of approval from the regulatory authorities in the Ukraine to commence a Phase IIa clinical study of THR-18, to be given with the clot buster drug tissue plasminogen activator (tPA), in patients with acute ischemic stroke. THR-18 is a synthetic therapeutic peptide ...


Evogene reports first quarter 2013 financial results


Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...


'Traffic' in our cells works both for and against us


A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells ...


Researchers from BGU have generated a promising drug candidate for the treatment of Psoriasis


Researchers from the Department of Life Sciences and the National Institute for Biotechnology in the Negev at Ben-Gurion University of the Negev in collaboration with Teva pharmaceutical industries LTD. have engineered a natural immune system receptor into a promising drug candidate for the ...


Page 1 From 9
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE